Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation. (Q52166351)

26 April 2018

title

Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation. (English)

1 reference

26 April 2018

author name string

Suzuki A

1

1 reference

26 April 2018

Hayashida M

2

1 reference

26 April 2018

Ito T

3

1 reference

26 April 2018

Kawano H

4

1 reference

26 April 2018

Nakano T

5

1 reference

26 April 2018

Miura M

6

1 reference

26 April 2018

Akahane K

7

1 reference

26 April 2018

Shiraki K

8

1 reference

26 April 2018

language of work or name

English

0 references

publication date

1 July 2000

1 reference

26 April 2018

published in

Oncogene

1 reference

26 April 2018

volume

19

1 reference

26 April 2018

issue

29

1 reference

26 April 2018

page(s)

3225-3234

1 reference

26 April 2018

https://scigraph.springernature.com/pub.10.1038/sj.onc.1203665

exact match

0 references

cites work

Human ICE/CED-3 protease nomenclature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

The retinoblastoma protein is phosphorylated during specific phases of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

Induction of the TRPM-2 gene in cells undergoing programmed death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

Tumor suppressor p16INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

Control of programmed cell death by the baculovirus genes p35 and iap.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

X-linked IAP is a direct inhibitor of cell-death proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

Prevention of vertebrate neuronal death by the crmA gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

Survivin promotes cell proliferation in human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

Control of apoptosis and mitotic spindle checkpoint by survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

Tumor necrosis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

Apoptosis regulated by a death factor and its receptor: Fas ligand and Fas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

Apoptosis by death factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

Inhibitors of mammalian G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

CDK inhibitors: positive and negative regulators of G1-phase progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

Mitochondrial regulation of cell death: mitochondria are essential for procaspase 3-p21 complex formation to resist Fas-mediated cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

Cell death: the significance of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

Inhibition of the Caenorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

Anti-apoptosis gene, survivin, and prognosis of neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

7 January 2021

Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

7 January 2021

The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

7 January 2021

A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

7 January 2021

The inhibitors of apoptosis (IAPs) and their emerging role in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

7 January 2021

Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

7 January 2021

Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

7 January 2021

Tumor Content of the Antiapoptosis Molecule Survivin and Recurrence of Bladder Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203665

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1203665

1 reference

26 April 2018

PubMed ID

10918579

1 reference

26 April 2018